263 related articles for article (PubMed ID: 31581380)
1. Latest Comprehensive Knowledge of the Crosstalk between TLR Signaling and Mycobacteria and the Antigens Driving the Process.
Kim JS; Kim YR; Yang CS
J Microbiol Biotechnol; 2019 Oct; 29(10):1506-1521. PubMed ID: 31581380
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis.
Mortaz E; Adcock IM; Tabarsi P; Masjedi MR; Mansouri D; Velayati AA; Casanova JL; Barnes PJ
J Clin Immunol; 2015 Jan; 35(1):1-10. PubMed ID: 25312698
[TBL] [Abstract][Full Text] [Related]
3. Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus.
Stamm CE; Collins AC; Shiloh MU
Immunol Rev; 2015 Mar; 264(1):204-19. PubMed ID: 25703561
[TBL] [Abstract][Full Text] [Related]
4. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
5. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations.
Källenius G; Correia-Neves M; Buteme H; Hamasur B; Svenson SB
Tuberculosis (Edinb); 2016 Jan; 96():120-30. PubMed ID: 26586646
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be-that is the question.
Gopalakrishnan A; Salgame P
Curr Opin Immunol; 2016 Oct; 42():76-82. PubMed ID: 27326654
[TBL] [Abstract][Full Text] [Related]
7. Innate immunity in tuberculosis: host defense vs pathogen evasion.
Liu CH; Liu H; Ge B
Cell Mol Immunol; 2017 Dec; 14(12):963-975. PubMed ID: 28890547
[TBL] [Abstract][Full Text] [Related]
8. Innate immune recognition in tuberculosis infection.
Tsolaki AG
Adv Exp Med Biol; 2009; 653():185-97. PubMed ID: 19799120
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Mycobacterium tuberculosis-dependent HIV-1 transcription reveals a new role for NFAT5 in the toll-like receptor pathway.
Ranjbar S; Jasenosky LD; Chow N; Goldfeld AE
PLoS Pathog; 2012; 8(4):e1002620. PubMed ID: 22496647
[TBL] [Abstract][Full Text] [Related]
10. Innate immune recognition of Mycobacterium tuberculosis.
Kleinnijenhuis J; Oosting M; Joosten LA; Netea MG; Van Crevel R
Clin Dev Immunol; 2011; 2011():405310. PubMed ID: 21603213
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor pathways in the immune responses to mycobacteria.
Quesniaux V; Fremond C; Jacobs M; Parida S; Nicolle D; Yeremeev V; Bihl F; Erard F; Botha T; Drennan M; Soler MN; Le Bert M; Schnyder B; Ryffel B
Microbes Infect; 2004 Aug; 6(10):946-59. PubMed ID: 15310472
[TBL] [Abstract][Full Text] [Related]
12. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis.
Reiling N; Ehlers S; Hölscher C
Immunol Lett; 2008 Feb; 116(1):15-23. PubMed ID: 18191460
[TBL] [Abstract][Full Text] [Related]
13. New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.
Faridgohar M; Nikoueinejad H
Pathog Glob Health; 2017 Jul; 111(5):256-264. PubMed ID: 28715935
[TBL] [Abstract][Full Text] [Related]
14. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
Tartey S; Takeuchi O
Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?
Berrington WR; Hawn TR
Immunol Rev; 2007 Oct; 219():167-86. PubMed ID: 17850489
[TBL] [Abstract][Full Text] [Related]
16. [Protective immunity against Mycobacterium tuberculosis].
Kawamura I
Kekkaku; 2006 Nov; 81(11):687-91. PubMed ID: 17154048
[TBL] [Abstract][Full Text] [Related]
17. Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection--the double-edged sword?
Hossain MM; Norazmi MN
Biomed Res Int; 2013; 2013():179174. PubMed ID: 24350246
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs.
Jo EK
Curr Opin Infect Dis; 2008 Jun; 21(3):279-86. PubMed ID: 18448973
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 1 variations influence susceptibility and immune response to Mycobacterium tuberculosis.
Dittrich N; Berrocal-Almanza LC; Thada S; Goyal S; Slevogt H; Sumanlatha G; Hussain A; Sur S; Burkert S; Oh DY; Valluri V; Schumann RR; Conrad ML
Tuberculosis (Edinb); 2015 May; 95(3):328-35. PubMed ID: 25857934
[TBL] [Abstract][Full Text] [Related]
20. Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to
Namdev P; Patel S; Sparling B; Garg A
Front Immunol; 2021; 12():647019. PubMed ID: 33995365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
